These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR, Abd-Elwahed SR, Abdulwahed AR. Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [Abstract] [Full Text] [Related]
3. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ. Cancer Res; 2006 May 15; 66(10):5278-86. PubMed ID: 16707453 [Abstract] [Full Text] [Related]
4. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Vincent-Salomon A, Lucchesi C, Gruel N, Raynal V, Pierron G, Goudefroye R, Reyal F, Radvanyi F, Salmon R, Thiery JP, Sastre-Garau X, Sigal-Zafrani B, Fourquet A, Delattre O, breast cancer study group of the Institut Curie. Clin Cancer Res; 2008 Apr 01; 14(7):1956-65. PubMed ID: 18381933 [Abstract] [Full Text] [Related]
6. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P. Hum Pathol; 2008 Mar 01; 39(3):386-92. PubMed ID: 18187183 [Abstract] [Full Text] [Related]
7. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Han W, Jung EM, Cho J, Lee JW, Hwang KT, Yang SJ, Kang JJ, Bae JY, Jeon YK, Park IA, Nicolau M, Jeffrey SS, Noh DY. Genes Chromosomes Cancer; 2008 Jun 01; 47(6):490-9. PubMed ID: 18314908 [Abstract] [Full Text] [Related]
10. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J. Cancer Res; 2003 Dec 15; 63(24):8861-8. PubMed ID: 14695203 [Abstract] [Full Text] [Related]
15. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. Marchiò C, Iravani M, Natrajan R, Lambros MB, Savage K, Tamber N, Fenwick K, Mackay A, Senetta R, Di Palma S, Schmitt FC, Bussolati G, Ellis LO, Ashworth A, Sapino A, Reis-Filho JS. J Pathol; 2008 Aug 15; 215(4):398-410. PubMed ID: 18484683 [Abstract] [Full Text] [Related]
16. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM. Breast Cancer Res; 2008 Aug 15; 10(5):R87. PubMed ID: 18928525 [Abstract] [Full Text] [Related]
17. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P. Hum Pathol; 2008 Dec 15; 39(12):1809-15. PubMed ID: 18715613 [Abstract] [Full Text] [Related]